These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36003772)

  • 61. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
    Koh CH; Bhoo-Pathy N; Ng KL; Jabir RS; Tan GH; See MH; Jamaris S; Taib NA
    Br J Cancer; 2015 Jun; 113(1):150-8. PubMed ID: 26022929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
    Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
    BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
    Kang Y; Zhu X; Lin Z; Zeng M; Shi P; Cao Y; Chen F
    Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542964
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma.
    Ishihara H; Tachibana H; Takagi T; Kondo T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Tanabe K
    Target Oncol; 2019 Aug; 14(4):453-463. PubMed ID: 31359231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
    Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I
    J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.
    Marín Hernández C; Piñero Madrona A; Gil Vázquez PJ; Galindo Fernández PJ; Ruiz Merino G; Alonso Romero JL; Parrilla Paricio P
    Clin Transl Oncol; 2018 Apr; 20(4):476-483. PubMed ID: 28785911
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The utility of pretreatment systemic inflammatory response biomarkers on overall survival of cervical cancer patients stratified by clinical staging.
    Santos Thuler LC; Reis Wariss B; Nogueira-Rodrigues A; de Melo AC; Bergmann A
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():281-288. PubMed ID: 34352424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
    Lusho S; Durando X; Bidet Y; Molnar I; Kossai M; Bernadach M; Lacrampe N; Veyssiere H; Cavaille M; Gay-Bellile M; Radosevic-Robin N; Abrial C
    Medicine (Baltimore); 2020 Dec; 99(50):e23418. PubMed ID: 33327268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors.
    Feng F; Tian Y; Liu S; Zheng G; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
    Medicine (Baltimore); 2016 Apr; 95(14):e3248. PubMed ID: 27057867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2
    Hu Y; Wang S; Ding N; Li N; Huang J; Xiao Z
    Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
    Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
    Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma.
    Song S; Bai M; Li X; Gong S; Yang W; Lei C; Tian H; Si M; Hao X; Guo T
    Expert Rev Mol Diagn; 2022 Mar; 22(3):361-378. PubMed ID: 35234564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.
    Uludag SS; Sanli AN; Zengin AK; Ozcelik MF
    Am Surg; 2022 Jun; 88(6):1256-1262. PubMed ID: 33596111
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
    Chen H; Wu X; Wen Z; Zhu Y; Liao L; Yang J
    Arch Esp Urol; 2022 Jun; 75(5):467-471. PubMed ID: 35983820
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review.
    Özdin S; Sarisoy G; Böke Ö
    Nord J Psychiatry; 2017 Oct; 71(7):509-512. PubMed ID: 28644753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as inflammatory markers in children with attention-deficit hyperactivity disorder.
    Avcil S
    Psychiatry Clin Neurosci; 2018 Jul; 72(7):522-530. PubMed ID: 29607599
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic Analysis of Preoperative Inflammatory Biomarkers in Patients With Laryngeal Squamous Cell Carcinoma.
    Xun Y; Wang M; Sun H; Shi S; Guan B; Yu C
    Ear Nose Throat J; 2020 Jul; 99(6):371-378. PubMed ID: 31569972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.